Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation.

Austin JW, Buckner CM, Kardava L, Wang W, Zhang X, Melson VA, Swanson RG, Martins AJ, Zhou JQ, Hoehn KB, Fisk JN, Dimopoulos Y, Chassiakos A, O'Dell S, Smelkinson MG, Seamon CA, Kwan RW, Sneller MC, Pittaluga S, Doria-Rose NA, McDermott A, Li Y, Chun TW, Kleinstein SH, Tsang JS, Petrovas C, Moir S.

Sci Transl Med. 2019 Nov 27;11(520). pii: eaax0904. doi: 10.1126/scitranslmed.aax0904.

PMID:
31776286
2.

rhIL-15 and anti-PD-L1 combination therapy expands a CXCR3+PD1-/low CD8 T cell subset in SIV-infected rhesus macaques.

Chen P, Chen H, Moussa M, Cheng J, Li T, Qin J, Lifson JD, Sneller MC, Krymskaya L, Godin S, Lane HC, Catalfamo M.

J Infect Dis. 2019 Sep 28. pii: jiz485. doi: 10.1093/infdis/jiz485. [Epub ahead of print]

PMID:
31562760
3.

An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals.

Sneller MC, Clarridge KE, Seamon C, Shi V, Zorawski MD, Justement JS, Blazkova J, Huiting ED, Proschan MA, Mora JR, Shetzline M, Moir S, Lane HC, Chun TW, Fauci AS.

Sci Transl Med. 2019 Sep 11;11(509). pii: eaax3447. doi: 10.1126/scitranslmed.aax3447. Epub 2019 Sep 5.

PMID:
31488581
4.

Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples.

Postnikova EN, Pettitt J, Van Ryn CJ, Holbrook MR, Bollinger L, Yú S, Caì Y, Liang J, Sneller MC, Jahrling PB, Hensley LE, Kuhn JH, Fallah MP, Bennett RS, Reilly C.

PLoS One. 2019 Aug 27;14(8):e0221407. doi: 10.1371/journal.pone.0221407. eCollection 2019.

5.

A Longitudinal Study of Ebola Sequelae in Liberia.

PREVAIL III Study Group, Sneller MC, Reilly C, Badio M, Bishop RJ, Eghrari AO, Moses SJ, Johnson KL, Gayedyu-Dennis D, Hensley LE, Higgs ES, Nath A, Tuznik K, Varughese J, Jensen KS, Dighero-Kemp B, Neaton JD, Lane HC, Fallah MP.

N Engl J Med. 2019 Mar 7;380(10):924-934. doi: 10.1056/NEJMoa1805435.

6.

Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection.

Huiting ED, Gittens K, Justement JS, Shi V, Blazkova J, Benko E, Kovacs C, Wender PA, Moir S, Sneller MC, Fauci AS, Chun TW.

J Infect Dis. 2019 Jun 19;220(2):270-274. doi: 10.1093/infdis/jiz100.

PMID:
30840763
7.

Ebola virus disease-related stigma among survivors declined in Liberia over an 18-month, post-outbreak period: An observational cohort study.

Kelly JD, Weiser SD, Wilson B, Cooper JB, Glayweon M, Sneller MC, Drew C, Steward WT, Reilly C, Johnson K, Fallah MP.

PLoS Negl Trop Dis. 2019 Feb 27;13(2):e0007185. doi: 10.1371/journal.pntd.0007185. eCollection 2019 Feb.

8.

IgG3 regulates tissue-like memory B cells in HIV-infected individuals.

Kardava L, Sohn H, Youn C, Austin JW, Wang W, Buckner CM, Justement JS, Melson VA, Roth GE, Hand MA, Gittens KR, Kwan RW, Sneller MC, Li Y, Chun TW, Sun PD, Pierce SK, Moir S.

Nat Immunol. 2018 Sep;19(9):1001-1012. doi: 10.1038/s41590-018-0180-5. Epub 2018 Aug 13.

9.

The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies.

Namazi G, Fajnzylber JM, Aga E, Bosch RJ, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, Smith DM, Kuritzkes DR, Gulick RM, Mellors JW, Mehraj V, Gandhi RT, Mitsuyasu R, Schooley RT, Henry K, Tebas P, Deeks SG, Chun TW, Collier AC, Routy JP, Hecht FM, Walker BD, Li JZ.

J Infect Dis. 2018 Nov 5;218(12):1954-1963. doi: 10.1093/infdis/jiy479.

10.

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.

Clarridge KE, Blazkova J, Einkauf K, Petrone M, Refsland EW, Justement JS, Shi V, Huiting ED, Seamon CA, Lee GQ, Yu XG, Moir S, Sneller MC, Lichterfeld M, Chun TW.

PLoS Pathog. 2018 Jan 11;14(1):e1006792. doi: 10.1371/journal.ppat.1006792. eCollection 2018 Jan.

11.

A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.

Sneller MC, Justement JS, Gittens KR, Petrone ME, Clarridge KE, Proschan MA, Kwan R, Shi V, Blazkova J, Refsland EW, Morris DE, Cohen KW, McElrath MJ, Xu R, Egan MA, Eldridge JH, Benko E, Kovacs C, Moir S, Chun TW, Fauci AS.

Sci Transl Med. 2017 Dec 6;9(419). pii: eaan8848. doi: 10.1126/scitranslmed.aan8848.

PMID:
29212716
12.

Cerebrospinal Fluid Examination in Survivors of Ebola Virus Disease.

Billioux BJ, Nath A, Stavale EJ, Dorbor J, Fallah MP, Sneller MC, Smith BR; Partnership for Research on Ebola Virus in Liberia (PREVAIL) III Study Group.

JAMA Neurol. 2017 Sep 1;74(9):1141-1143. doi: 10.1001/jamaneurol.2017.1460. No abstract available.

13.

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.

Bar KJ, Sneller MC, Harrison LJ, Justement JS, Overton ET, Petrone ME, Salantes DB, Seamon CA, Scheinfeld B, Kwan RW, Learn GH, Proschan MA, Kreider EF, Blazkova J, Bardsley M, Refsland EW, Messer M, Clarridge KE, Tustin NB, Madden PJ, Oden K, O'Dell SJ, Jarocki B, Shiakolas AR, Tressler RL, Doria-Rose NA, Bailer RT, Ledgerwood JE, Capparelli EV, Lynch RM, Graham BS, Moir S, Koup RA, Mascola JR, Hoxie JA, Fauci AS, Tebas P, Chun TW.

N Engl J Med. 2016 Nov 24;375(21):2037-2050. Epub 2016 Nov 9.

14.

Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab).

Gill AL, Green SA, Abdullah S, Le Saout C, Pittaluga S, Chen H, Turnier R, Lifson J, Godin S, Qin J, Sneller MC, Cuillerot JM, Sabzevari H, Lane HC, Catalfamo M.

AIDS. 2016 Oct 23;30(16):2487-2493.

15.

Decline of cellular activation in non-B cells after rituximab treatment in hepatitis C-associated mixed cryoglobulinemia vasculitis.

Emmanuel B, Sidique N, Zhang X, Poonia B, Sneller MC, Kottilil S.

J Viral Hepat. 2017 Feb;24(2):128-131. doi: 10.1111/jvh.12618. Epub 2016 Sep 25.

16.

Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC.

Kassaye SG, Grossman Z, Balamane M, Johnston-White B, Liu C, Kumar P, Young M, Sneller MC, Sereti I, Dewar R, Rehm C, Meyer W 3rd, Shafer R, Katzenstein D, Maldarelli F.

Clin Infect Dis. 2016 Sep 15;63(6):836-843. doi: 10.1093/cid/ciw382. Epub 2016 Jun 15.

17.

Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients.

Grant PM, Sheikh V, DerSimonian R, Rupert A, Roby G, Pau A, Sneller MC, Rico SV, Brown TT, Sereti I.

AIDS Res Hum Retroviruses. 2015 Jul;31(7):739-44. doi: 10.1089/AID.2015.0028. Epub 2015 May 21.

18.

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

Conlon KC, Lugli E, Welles HC, Rosenberg SA, Fojo AT, Morris JC, Fleisher TA, Dubois SP, Perera LP, Stewart DM, Goldman CK, Bryant BR, Decker JM, Chen J, Worthy TA, Figg WD Sr, Peer CJ, Sneller MC, Lane HC, Yovandich JL, Creekmore SP, Roederer M, Waldmann TA.

J Clin Oncol. 2015 Jan 1;33(1):74-82. doi: 10.1200/JCO.2014.57.3329. Epub 2014 Nov 17.

19.

Hepatitis C-associated mixed cryoglobulinemic vasculitis induces differential gene expression in peripheral mononuclear cells.

Sidharthan S, Kim CW, Murphy AA, Zhang X, Yang J, Lempicki RA, Sneller MC, Kottilil S.

Front Immunol. 2014 May 27;5:248. doi: 10.3389/fimmu.2014.00248. eCollection 2014.

20.

Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis.

Le Saout C, Hasley RB, Imamichi H, Tcheung L, Hu Z, Luckey MA, Park JH, Durum SK, Smith M, Rupert AW, Sneller MC, Lane HC, Catalfamo M.

PLoS Pathog. 2014 Mar 6;10(3):e1003976. doi: 10.1371/journal.ppat.1003976. eCollection 2014 Mar.

21.

HIV/IL-2 and EBV-associated lymphoproliferative diseases: cause and effect or coincidence?

Sneller MC, Lane HC.

HIV Med. 2014 Jan;15(1):1-2. doi: 10.1111/hiv.12092. No abstract available.

22.

HIV immune activation drives increased Eomes expression in memory CD8 T cells in association with transcriptional downregulation of CD127.

Hasley RB, Hong C, Li W, Friesen T, Nakamura Y, Kim GY, Park JH, Hixon JA, Durum S, Hu Z, Sneller MC, Oguariri R, Imamichi T, Lane HC, Catalfamo M.

AIDS. 2013 Jul 31;27(12):1867-77. doi: 10.1097/QAD.0b013e3283618487.

PMID:
23965471
23.

Reply: b-cell frequency in HCV-related mixed cryoglobulinemia.

Holz LE, Yoon JC, Raghuraman S, Moir S, Sneller MC, Rehermann B.

Hepatology. 2013 Jul;58(1):448-9. doi: 10.1002/hep.26112. Epub 2013 May 29. No abstract available.

PMID:
23111813
24.

B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naïve B cell apoptosis.

Holz LE, Yoon JC, Raghuraman S, Moir S, Sneller MC, Rehermann B.

Hepatology. 2012 Nov;56(5):1602-10. doi: 10.1002/hep.25821. Epub 2012 Oct 14.

25.
26.

IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood.

Sneller MC, Kopp WC, Engelke KJ, Yovandich JL, Creekmore SP, Waldmann TA, Lane HC.

Blood. 2011 Dec 22;118(26):6845-8. doi: 10.1182/blood-2011-09-377804. Epub 2011 Nov 8.

27.

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques.

Waldmann TA, Lugli E, Roederer M, Perera LP, Smedley JV, Macallister RP, Goldman CK, Bryant BR, Decker JM, Fleisher TA, Lane HC, Sneller MC, Kurlander RJ, Kleiner DE, Pletcher JM, Figg WD, Yovandich JL, Creekmore SP.

Blood. 2011 May 5;117(18):4787-95. doi: 10.1182/blood-2010-10-311456. Epub 2011 Mar 8.

28.

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals.

Ho J, Moir S, Wang W, Posada JG, Gu W, Rehman MT, Dewar R, Kovacs C, Sneller MC, Chun TW, Follmann DA, Fauci AS.

AIDS. 2011 Jan 28;25(3):295-302. doi: 10.1097/QAD.0b013e328342328b.

29.

Pathogenesis of Wegener's granulomatosis: current concepts.

Sarraf P, Sneller MC.

Expert Rev Mol Med. 2005 May 13;7(8):1-19. Review.

PMID:
15890083
30.

Orbital socket contracture: a complication of inflammatory orbital disease in patients with Wegener's granulomatosis.

Talar-Williams C, Sneller MC, Langford CA, Smith JA, Cox TA, Robinson MR.

Br J Ophthalmol. 2005 Apr;89(4):493-7.

31.

Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?

Sneller MC.

Arthritis Rheum. 2005 Jan;52(1):1-5. Review. No abstract available.

32.

Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccine-provoked vasculitis.

Begier EM, Langford CA, Sneller MC, Wise RP, Ball R; VAERS Working Group.

J Rheumatol. 2004 Nov;31(11):2181-8.

PMID:
15517631
33.

Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis.

Langford CA, Talar-Williams C, Sneller MC.

Arthritis Rheum. 2004 Apr 15;51(2):278-83.

34.

Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia.

Kottilil S, Shin K, Planta M, McLaughlin M, Hallahan CW, Ghany M, Chun TW, Sneller MC, Fauci AS.

J Infect Dis. 2004 Apr 1;189(7):1193-8. Epub 2004 Mar 16.

PMID:
15031787
35.

Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.

Yamashita K, Choi U, Woltz PC, Foster SF, Sneller MC, Hakim FT, Fowler DH, Bishop MR, Pavletic SZ, Tamari M, Castro K, Barrett AJ, Childs RW, Illei GG, Leitman SF, Malech HL, Horwitz ME.

Blood. 2004 May 15;103(10):3986-8. Epub 2004 Feb 5.

PMID:
14764530
36.

Tarsal-conjunctival disease associated with Wegener's granulomatosis.

Robinson MR, Lee SS, Sneller MC, Lerner R, Langford CA, Talar-Williams C, Cox TA, Chan CC, Smith JA.

Ophthalmology. 2003 Sep;110(9):1770-80.

PMID:
13129876
37.

Autoimmune lymphoproliferative syndrome.

Sneller MC, Dale JK, Straus SE.

Curr Opin Rheumatol. 2003 Jul;15(4):417-21. Review.

PMID:
12819469
38.
39.

Biologic therapies in the vasculitides.

Langford CA, Sneller MC.

Curr Opin Rheumatol. 2003 Jan;15(1):3-10. Review.

PMID:
12496503
40.

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, Cohen P, Calabrese LH, Dickler H, Merkel PA, Fortin P, Flynn JA, Locker GA, Easley KA, Schned E, Hunder GG, Sneller MC, Tuggle C, Swanson H, Hernández-Rodríguez J, Lopez-Soto A, Bork D, Hoffman DB, Kalunian K, Klashman D, Wilke WS, Scheetz RJ, Mandell BF, Fessler BJ, Kosmorsky G, Prayson R, Luqmani RA, Nuki G, McRorie E, Sherrer Y, Baca S, Walsh B, Ferland D, Soubrier M, Choi HK, Gross W, Segal AM, Ludivico C, Puechal X; International Network for the Study of Systemic Vasculitides.

Arthritis Rheum. 2002 May;46(5):1309-18.

41.

Granuloma formation, implications for the pathogenesis of vasculitis.

Sneller MC.

Cleve Clin J Med. 2002;69 Suppl 2:SII40-3. Review.

PMID:
12086263
42.

CT virtual bronchoscopy of the central airways in patients with Wegener's granulomatosis.

Summers RM, Aggarwal NR, Sneller MC, Cowan MJ, Wood BJ, Langford CA, Shelhamer JH.

Chest. 2002 Jan;121(1):242-50.

PMID:
11796457
43.

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.

Straus SE, Jaffe ES, Puck JM, Dale JK, Elkon KB, Rösen-Wolff A, Peters AM, Sneller MC, Hallahan CW, Wang J, Fischer RE, Jackson CE, Lin AY, Bäumler C, Siegert E, Marx A, Vaishnaw AK, Grodzicky T, Fleisher TA, Lenardo MJ.

Blood. 2001 Jul 1;98(1):194-200.

PMID:
11418480
44.

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.

Lopatin U, Yao X, Williams RK, Bleesing JJ, Dale JK, Wong D, Teruya-Feldstein J, Fritz S, Morrow MR, Fuss I, Sneller MC, Raffeld M, Fleisher TA, Puck JM, Strober W, Jaffe ES, Straus SE.

Blood. 2001 May 15;97(10):3161-70.

PMID:
11342444
45.

Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature.

Tarr PE, Sneller MC, Mechanic LJ, Economides A, Eger CM, Strober W, Cunningham-Rundles C, Lucey DR.

Medicine (Baltimore). 2001 Mar;80(2):123-33. Review.

46.

Common variable immunodeficiency.

Sneller MC.

Am J Med Sci. 2001 Jan;321(1):42-8. Review.

PMID:
11202479
47.

Update on the diagnosis and treatment of Wegener's granulomatosis.

Langford CA, Sneller MC.

Adv Intern Med. 2001;46:177-206. Review. No abstract available.

PMID:
11147253
48.
49.
50.

Report of a factor VIII inhibitor in a patient with autoimmune lymphoproliferative syndrome.

Fang BS, Sneller MC, Straus SE, Frenkel L, Dale JK, Rick ME.

Am J Hematol. 2000 Jul;64(3):214-7.

Supplemental Content

Loading ...
Support Center